Liaoning Huarui United Pharmaceutical Co., Ltd.

The company was founded in 1987 and was originally affiliated with the "Northeast Pharmaceutical Group." The company is located in Dandong City, the largest border city in China. The environment is superior and the transportation is convenient. The company covers an area of 36,000 square meters and a building area of 14,700 square meters. The company has an independent research and development laboratory, as well as ordinary solid preparations, cefoid solid preparations, raw materials for emulsion tincture, and five workshops for extraction of Chinese medicine. Annual production of 3 billion tablets, 4 billion capsules, 100 million bags of granules, and 50 million pieces of ointment. In June 2015, it passed China's new GMP certification. After more than 10 years of continuous accumulation and innovation, a core model enterprise with an annual output value of nearly 200 million yuan has been formed, focusing on oral preparations, placing equal emphasis on Chinese and Western medicines, and combining adult medicines and children's medicines. The main products are cefaxil methoxazepridine capsules(tablets), cefkelo capsules, cefradine capsules(granules), roxithromycin capsules(granules), compound amphenolamine tablets, norfloxacin capsules, phosphorycin calcium tablets, aminopyrin caffeine tablets, compound acetate dexamethasone cream More than 100 varieties such as vitamin A acid cream.